vs

Side-by-side financial comparison of COMMUNITY HEALTH SYSTEMS INC (CYH) and Venture Global, Inc. (VG). Click either name above to swap in a different company.

Venture Global, Inc. is the larger business by last-quarter revenue ($4.4B vs $3.1B, roughly 1.4× COMMUNITY HEALTH SYSTEMS INC). Venture Global, Inc. runs the higher net margin — 26.8% vs 3.5%, a 23.3% gap on every dollar of revenue. On growth, Venture Global, Inc. posted the faster year-over-year revenue change (191.7% vs -4.8%). COMMUNITY HEALTH SYSTEMS INC produced more free cash flow last quarter ($172.0M vs $-1.5B). Over the past eight quarters, Venture Global, Inc.'s revenue compounded faster (77.3% CAGR vs -0.5%).

Community Health Systems (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

S&P Global Inc. is an American publicly traded corporation headquartered in Manhattan, New York. Its primary areas of business are financial information, analytics, and energy and commodities intelligence. It is the parent company of S&P Global Ratings, S&P Global Energy, S&P Global Market Intelligence, S&P Global Mobility, and the Indian credit rating agency CRISIL. It is also the majority owner of the S&P Dow Jones Indices joint venture. "S&P" is a shortening of "Standard and Poor's".

CYH vs VG — Head-to-Head

Bigger by revenue
VG
VG
1.4× larger
VG
$4.4B
$3.1B
CYH
Growing faster (revenue YoY)
VG
VG
+196.5% gap
VG
191.7%
-4.8%
CYH
Higher net margin
VG
VG
23.3% more per $
VG
26.8%
3.5%
CYH
More free cash flow
CYH
CYH
$1.7B more FCF
CYH
$172.0M
$-1.5B
VG
Faster 2-yr revenue CAGR
VG
VG
Annualised
VG
77.3%
-0.5%
CYH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CYH
CYH
VG
VG
Revenue
$3.1B
$4.4B
Net Profit
$110.0M
$1.2B
Gross Margin
85.6%
Operating Margin
14.5%
38.7%
Net Margin
3.5%
26.8%
Revenue YoY
-4.8%
191.7%
Net Profit YoY
254.9%
20.3%
EPS (diluted)
$0.82
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYH
CYH
VG
VG
Q4 25
$3.1B
$4.4B
Q3 25
$3.1B
$3.3B
Q2 25
$3.1B
$3.1B
Q1 25
$3.2B
$2.9B
Q4 24
$3.3B
$1.5B
Q3 24
$3.1B
$926.0M
Q2 24
$3.1B
$1.1B
Q1 24
$3.1B
$1.4B
Net Profit
CYH
CYH
VG
VG
Q4 25
$110.0M
$1.2B
Q3 25
$130.0M
$550.0M
Q2 25
$282.0M
$475.0M
Q1 25
$-13.0M
$517.0M
Q4 24
$-71.0M
$990.0M
Q3 24
$-391.0M
$-294.0M
Q2 24
$-13.0M
$352.0M
Q1 24
$-41.0M
$698.0M
Gross Margin
CYH
CYH
VG
VG
Q4 25
85.6%
Q3 25
85.1%
Q2 25
85.0%
Q1 25
84.5%
Q4 24
84.5%
Q3 24
84.8%
Q2 24
84.6%
Q1 24
84.5%
Operating Margin
CYH
CYH
VG
VG
Q4 25
14.5%
38.7%
Q3 25
7.9%
39.7%
Q2 25
16.3%
33.5%
Q1 25
9.0%
37.3%
Q4 24
8.5%
39.0%
Q3 24
-6.6%
20.4%
Q2 24
7.6%
32.8%
Q1 24
7.4%
43.6%
Net Margin
CYH
CYH
VG
VG
Q4 25
3.5%
26.8%
Q3 25
4.2%
16.5%
Q2 25
9.0%
15.3%
Q1 25
-0.4%
17.9%
Q4 24
-2.2%
65.0%
Q3 24
-12.7%
-31.7%
Q2 24
-0.4%
31.8%
Q1 24
-1.3%
49.4%
EPS (diluted)
CYH
CYH
VG
VG
Q4 25
$0.82
$0.41
Q3 25
$0.96
$0.16
Q2 25
$2.09
$0.14
Q1 25
$-0.10
$0.15
Q4 24
$-0.53
$0.35
Q3 24
$-2.95
$-0.15
Q2 24
$-0.10
$0.12
Q1 24
$-0.32
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYH
CYH
VG
VG
Cash + ST InvestmentsLiquidity on hand
$260.0M
$2.4B
Total DebtLower is stronger
$10.4B
$34.2B
Stockholders' EquityBook value
$-1.4B
$6.7B
Total Assets
$13.2B
$53.4B
Debt / EquityLower = less leverage
5.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYH
CYH
VG
VG
Q4 25
$260.0M
$2.4B
Q3 25
$123.0M
$1.9B
Q2 25
$456.0M
$2.2B
Q1 25
$431.0M
$3.6B
Q4 24
$37.0M
$3.6B
Q3 24
$33.0M
Q2 24
$39.0M
Q1 24
$48.0M
Total Debt
CYH
CYH
VG
VG
Q4 25
$10.4B
$34.2B
Q3 25
$32.6B
Q2 25
$30.0B
Q1 25
$29.3B
Q4 24
$11.5B
$29.3B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CYH
CYH
VG
VG
Q4 25
$-1.4B
$6.7B
Q3 25
$-1.5B
$5.7B
Q2 25
$-1.6B
$5.3B
Q1 25
$-1.9B
$4.9B
Q4 24
$-1.9B
$2.9B
Q3 24
$-1.8B
Q2 24
$-1.4B
Q1 24
$-1.4B
Total Assets
CYH
CYH
VG
VG
Q4 25
$13.2B
$53.4B
Q3 25
$13.2B
$50.1B
Q2 25
$13.6B
$46.5B
Q1 25
$13.9B
$45.1B
Q4 24
$14.1B
$43.5B
Q3 24
$13.9B
Q2 24
$14.4B
Q1 24
$14.4B
Debt / Equity
CYH
CYH
VG
VG
Q4 25
5.07×
Q3 25
5.73×
Q2 25
5.69×
Q1 25
6.01×
Q4 24
10.11×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYH
CYH
VG
VG
Operating Cash FlowLast quarter
$266.0M
$2.1B
Free Cash FlowOCF − Capex
$172.0M
$-1.5B
FCF MarginFCF / Revenue
5.5%
-34.1%
Capex IntensityCapex / Revenue
3.0%
81.6%
Cash ConversionOCF / Net Profit
2.42×
1.77×
TTM Free Cash FlowTrailing 4 quarters
$208.0M
$-6.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYH
CYH
VG
VG
Q4 25
$266.0M
$2.1B
Q3 25
$69.0M
$1.9B
Q2 25
$88.0M
$1.5B
Q1 25
$120.0M
$1.1B
Q4 24
$216.0M
Q3 24
$67.0M
Q2 24
$101.0M
Q1 24
$96.0M
$638.0M
Free Cash Flow
CYH
CYH
VG
VG
Q4 25
$172.0M
$-1.5B
Q3 25
$4.0M
$-1.4B
Q2 25
$-3.0M
$-1.5B
Q1 25
$35.0M
$-2.4B
Q4 24
$107.0M
Q3 24
$-3.0M
Q2 24
$13.0M
Q1 24
$3.0M
$-2.4B
FCF Margin
CYH
CYH
VG
VG
Q4 25
5.5%
-34.1%
Q3 25
0.1%
-42.4%
Q2 25
-0.1%
-49.1%
Q1 25
1.1%
-81.3%
Q4 24
3.3%
Q3 24
-0.1%
Q2 24
0.4%
Q1 24
0.1%
-167.3%
Capex Intensity
CYH
CYH
VG
VG
Q4 25
3.0%
81.6%
Q3 25
2.1%
98.9%
Q2 25
2.9%
96.1%
Q1 25
2.7%
119.8%
Q4 24
3.3%
Q3 24
2.3%
Q2 24
2.8%
Q1 24
3.0%
212.4%
Cash Conversion
CYH
CYH
VG
VG
Q4 25
2.42×
1.77×
Q3 25
0.53×
3.42×
Q2 25
0.31×
3.07×
Q1 25
2.15×
Q4 24
Q3 24
Q2 24
Q1 24
0.91×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CYH
CYH

Managed Care And Other Third Party Payors$1.5B49%
Medicare Managed Care$570.0M18%
Medicare$512.0M16%
Medicaid$464.0M15%
Self Pay Revenue$34.0M1%

VG
VG

Plaquemines Project Segment$3.4B76%
Calcasieu Project Segment$841.0M19%
Other$208.0M5%

Related Comparisons